Candesartan pretreatment is cerebroprotective in a rat model of endothelin‐1‐induced middle cerebral artery occlusion
Authors:
Open Access
- 13 July 2009
- journal article
- research article
- Published by Wiley in Experimental Physiology
- Vol. 94 (8) , 937-946
Abstract
Endogenous levels of angiotensin II (Ang II) are increased in the cortex and hypothalamus following stroke, and Ang II type 1 receptor blockers (ARBs) have been shown to attenuate the deleterious eff...Keywords
This publication has 40 references indexed in Scilit:
- Angiotensin AT 2 Receptor Stimulation Causes Neuroprotection in a Conscious Rat Model of StrokeStroke, 2009
- Excess Salt Causes Cerebral Neuronal Apoptosis and Inflammation in Stroke-Prone Hypertensive Rats Through Angiotensin II-Induced NADPH Oxidase ActivationStroke, 2008
- Protective effect of estrogen in endothelin-induced middle cerebral artery occlusion in female ratsNeuroscience Letters, 2008
- Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptorsJournal Of Hypertension, 2008
- Temporary Pretreatment With the Angiotensin II Type 1 Receptor Blocker, Valsartan, Prevents Ischemic Brain Damage Through an Increase in Capillary DensityStroke, 2008
- Cardiovascular and Renal Regulation by the Angiotensin Type 2 ReceptorHypertension, 2005
- Protection Against Ischemia and Improvement of Cerebral Blood Flow in Genetically Hypertensive Rats by Chronic Pretreatment With an Angiotensin II AT 1 AntagonistStroke, 2002
- Blockade of Central Angiotensin AT1Receptors Improves Neurological Outcome and Reduces Expression of AP-1 Transcription Factors After Focal Brain Ischemia in RatsStroke, 1999
- Neurological Deficit and Extent of Neuronal Necrosis Attributable to Middle Cerebral Artery Occlusion in RatsStroke, 1995
- Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.Stroke, 1986